课题基金 / 基金详情

CORE--TRANSGENIC/GENE DISRUPTION MOUSE

CORE--TRANSGENIC/GENE DISRUPTION MOUSE
核心--转基因/基因破坏小鼠
批准号:
6356262
负责人:
STEVEN D SHAPIRO
金额:
$21.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-01 至 2001-08-31

项目摘要

项目成果

STEVEN D SHAPIRO的其他基金

相似基金

相关文献

中文摘要
翻译
转基因/基因干扰小鼠核心研究的主要目标 是提供一个集中的面向服务的设施,它将 确保每个参与项目实验室的生产能力 转基因和基因破坏的小鼠。此外,这将导致 通过避免重复工作来节省工作量和费用 需要专门设备和专业技能的高技能 动物设施。转基因/基因中断的核心是 合作的主要途径。能够执行以下操作 体内的功能和丧失功能的实验将增强我们的 对引导呼吸道的分子机制的认识 炎症与哮喘的发病机制。此外, 跟踪组织和细胞类型表达的能力 启动子/增强子结合在正常胚胎和 成人的发展对加深我们对 呼吸道分化和炎症的调节。
英文摘要
The major objective of the Transgenic / Gene-Disruption Mouse Core is to provide a centralized service oriented facility that will insure the capacity of each participating project lab to produce transgenic and gene-disrupted mice. Moreover, this will result in an economy of effort as well as expense by avoiding duplication of a highly technical skill requiring specialized equipment and animal facilities. The Transgenic / Gene-Disruption Core is a major avenue for collaborations. The ability to perform gain of function and loss of function experiments in vivo will enhance our understanding of the molecular mechanisms guiding airway inflammation and the pathogenesis of asthma. Moreover, the capacity to follow the tissue and cell type expression of a Promoter/Enhancer combination throughout normal embryonic and adult development is crucial to furthering our understanding of airway differentiation and regulation of inflammation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Emphysematous Microenvironment Promotes Lung Tumorigenesis and Progression
Genetics of Asthma and COPD
  • 批准号:
    7218219
  • 项目类别:
  • 资助金额:
    $84.8万
  • 财政年份:
    2006
  • 负责人:
    STEVEN D SHAPIRO
  • 依托单位:
Genetic and Environmental Factors Affecting COPD Exacer*
Genetic and Environmental Factors--COPD Exacerbations
  • 批准号:
    7008368
  • 项目类别:
  • 资助金额:
    $44.13万
  • 财政年份:
    2005
  • 负责人:
    STEVEN D SHAPIRO
  • 依托单位:
海外基金